A detailed history of Logos Global Management LP transactions in Arcellx, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 165,000 shares of ACLX stock, worth $14.8 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares
165,000
Holding current value
$14.8 Million
% of portfolio
1.57%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$64.69 - $82.1 $10.7 Million - $13.5 Million
165,000 New
165,000 $13.5 Million
Q2 2023

Aug 14, 2023

BUY
$27.49 - $46.9 $13.7 Million - $23.5 Million
500,000 New
500,000 $15.8 Million

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.94B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.